IL17A and colorectal cancer: IL-17, MMP-9 and CD23 were negatively correlated with treatment time, suggesting that the recovery of patients with colorectal cancer can be estimated by detecting the concentrations of IL-17, MMP-9 and CD23 in peripheral blood of patients.